| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 1,027,000 | 1,190,000 | 1,084,000 | 1,138,000 | | Cost of Revenue | 734,000 | 874,000 | 759,000 | 785,000 | | | Gross Profit | 293,000 | 316,000 | 325,000 | 353,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 109,000 | 127,000 | 108,000 | 118,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 184,000 | 189,000 | 217,000 | 235,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 7,000 | 3,000 | 8,000 | | Earnings Before Interest And Taxes | 187,000 | 196,000 | 220,000 | 243,000 | | Interest Expense | 6,000 | 6,000 | 5,000 | 3,000 | | Income Before Tax | 181,000 | 190,000 | 215,000 | 240,000 | | Income Tax Expense | 60,000 | 56,000 | 70,000 | 76,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 121,000 | 134,000 | 145,000 | 164,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 121,000 | 134,000 | 145,000 | 164,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $121,000 | $134,000 | $145,000 | $164,000 |
|
1.52% Nasdaq 0.00%
Income Statement
